CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of enteric diseases
3.4.1.2. Untapped market in developing countries
3.4.2. Restraints
3.4.2.1. High cost associated with molecular diagnostic assay
3.4.3. Opportunities
3.4.3.1. Rise in adoption of developmental strategies by key players
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Equipment
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Molecular Diagnostics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Immunodiagnostics
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Bacterial Enteric Disease
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Viral Enteric Disease
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Parasitic Enteric Disease
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: ENTERIC DISEASE TESTING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospital Laboratories
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pharmaceutical and Biotechnology Companies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Institutes
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: ENTERIC DISEASE TESTING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Disease Type
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product Type
8.2.6.1.3. Market size and forecast, by Technique
8.2.6.1.4. Market size and forecast, by Disease Type
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product Type
8.2.6.2.3. Market size and forecast, by Technique
8.2.6.2.4. Market size and forecast, by Disease Type
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product Type
8.2.6.3.3. Market size and forecast, by Technique
8.2.6.3.4. Market size and forecast, by Disease Type
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Disease Type
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product Type
8.3.6.1.3. Market size and forecast, by Technique
8.3.6.1.4. Market size and forecast, by Disease Type
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product Type
8.3.6.2.3. Market size and forecast, by Technique
8.3.6.2.4. Market size and forecast, by Disease Type
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product Type
8.3.6.3.3. Market size and forecast, by Technique
8.3.6.3.4. Market size and forecast, by Disease Type
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product Type
8.3.6.4.3. Market size and forecast, by Technique
8.3.6.4.4. Market size and forecast, by Disease Type
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product Type
8.3.6.5.3. Market size and forecast, by Technique
8.3.6.5.4. Market size and forecast, by Disease Type
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product Type
8.3.6.6.3. Market size and forecast, by Technique
8.3.6.6.4. Market size and forecast, by Disease Type
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Disease Type
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product Type
8.4.6.1.3. Market size and forecast, by Technique
8.4.6.1.4. Market size and forecast, by Disease Type
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product Type
8.4.6.2.3. Market size and forecast, by Technique
8.4.6.2.4. Market size and forecast, by Disease Type
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product Type
8.4.6.3.3. Market size and forecast, by Technique
8.4.6.3.4. Market size and forecast, by Disease Type
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. India
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product Type
8.4.6.4.3. Market size and forecast, by Technique
8.4.6.4.4. Market size and forecast, by Disease Type
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product Type
8.4.6.5.3. Market size and forecast, by Technique
8.4.6.5.4. Market size and forecast, by Disease Type
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product Type
8.4.6.6.3. Market size and forecast, by Technique
8.4.6.6.4. Market size and forecast, by Disease Type
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Disease Type
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product Type
8.5.6.1.3. Market size and forecast, by Technique
8.5.6.1.4. Market size and forecast, by Disease Type
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product Type
8.5.6.2.3. Market size and forecast, by Technique
8.5.6.2.4. Market size and forecast, by Disease Type
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product Type
8.5.6.3.3. Market size and forecast, by Technique
8.5.6.3.4. Market size and forecast, by Disease Type
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product Type
8.5.6.4.3. Market size and forecast, by Technique
8.5.6.4.4. Market size and forecast, by Disease Type
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Becton Dickinson & Company
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Biomerica, Inc.
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Biomerieux SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Diasorin S.p.A.
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Meridian Bioscience Inc.
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Quest Diagnostics Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. Trinity Biotech
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Coris BioConcept
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Abbott Laboratories
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
List of Tables
TABLE 01. GLOBAL ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. ENTERIC DISEASE TESTING MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. ENTERIC DISEASE TESTING MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 05. ENTERIC DISEASE TESTING MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. ENTERIC DISEASE TESTING MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GLOBAL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 08. ENTERIC DISEASE TESTING MARKET FOR BACTERIAL ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 09. ENTERIC DISEASE TESTING MARKET FOR VIRAL ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 10. ENTERIC DISEASE TESTING MARKET FOR PARASITIC ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. ENTERIC DISEASE TESTING MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. ENTERIC DISEASE TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 14. ENTERIC DISEASE TESTING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
TABLE 15. ENTERIC DISEASE TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 21. U.S. ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 22. U.S. ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 23. U.S. ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 24. U.S. ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 25. CANADA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 26. CANADA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 27. CANADA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 28. CANADA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. MEXICO ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 30. MEXICO ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 31. MEXICO ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 32. MEXICO ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. EUROPE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 34. EUROPE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 35. EUROPE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 36. EUROPE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. EUROPE ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 38. GERMANY ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 39. GERMANY ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 40. GERMANY ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 41. GERMANY ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. FRANCE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 43. FRANCE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 44. FRANCE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 45. FRANCE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. UK ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 47. UK ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 48. UK ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 49. UK ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 50. ITALY ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 51. ITALY ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 52. ITALY ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 53. ITALY ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. SPAIN ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 55. SPAIN ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 56. SPAIN ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 57. SPAIN ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 59. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 60. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 61. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 63. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 64. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 65. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 66. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 67. JAPAN ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 68. JAPAN ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 69. JAPAN ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 70. JAPAN ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. CHINA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 72. CHINA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 73. CHINA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 74. CHINA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 75. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 76. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 77. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 78. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. INDIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 80. INDIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 81. INDIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 82. INDIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 84. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 85. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 86. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 91. LAMEA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 92. LAMEA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 93. LAMEA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 94. LAMEA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 95. LAMEA ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 96. BRAZIL ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 97. BRAZIL ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 98. BRAZIL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 99. BRAZIL ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 100. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 101. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 102. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 103. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 105. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 106. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 107. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 108. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 109. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 110. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 111. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 112. BECTON DICKINSON & COMPANY: KEY EXECUTIVES
TABLE 113. BECTON DICKINSON & COMPANY: COMPANY SNAPSHOT
TABLE 114. BECTON DICKINSON & COMPANY: PRODUCT SEGMENTS
TABLE 115. BECTON DICKINSON & COMPANY: PRODUCT PORTFOLIO
TABLE 116. BIOMERICA, INC.: KEY EXECUTIVES
TABLE 117. BIOMERICA, INC.: COMPANY SNAPSHOT
TABLE 118. BIOMERICA, INC.: PRODUCT SEGMENTS
TABLE 119. BIOMERICA, INC.: PRODUCT PORTFOLIO
TABLE 120. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 121. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 122. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 123. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 124. BIOMERIEUX SA: KEY STRATEGIES
TABLE 125. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 126. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 127. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
TABLE 128. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 129. DIASORIN S.P.A.: KEY EXECUTIVES
TABLE 130. DIASORIN S.P.A.: COMPANY SNAPSHOT
TABLE 131. DIASORIN S.P.A.: PRODUCT SEGMENTS
TABLE 132. DIASORIN S.P.A.: PRODUCT PORTFOLIO
TABLE 133. DIASORIN S.P.A.: KEY STRATEGIES
TABLE 134. MERIDIAN BIOSCIENCE INC.: KEY EXECUTIVES
TABLE 135. MERIDIAN BIOSCIENCE INC.: COMPANY SNAPSHOT
TABLE 136. MERIDIAN BIOSCIENCE INC.: PRODUCT SEGMENTS
TABLE 137. MERIDIAN BIOSCIENCE INC.: PRODUCT PORTFOLIO
TABLE 138. MERIDIAN BIOSCIENCE INC.: KEY STRATEGIES
TABLE 139. QUEST DIAGNOSTICS INC.: KEY EXECUTIVES
TABLE 140. QUEST DIAGNOSTICS INC.: COMPANY SNAPSHOT
TABLE 141. QUEST DIAGNOSTICS INC.: SERVICE SEGMENTS
TABLE 142. QUEST DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 143. QUEST DIAGNOSTICS INC.: KEY STRATEGIES
TABLE 144. TRINITY BIOTECH: KEY EXECUTIVES
TABLE 145. TRINITY BIOTECH: COMPANY SNAPSHOT
TABLE 146. TRINITY BIOTECH: PRODUCT SEGMENTS
TABLE 147. TRINITY BIOTECH: PRODUCT PORTFOLIO
TABLE 148. TRINITY BIOTECH: KEY STRATEGIES
TABLE 149. CORIS BIOCONCEPT: KEY EXECUTIVES
TABLE 150. CORIS BIOCONCEPT: COMPANY SNAPSHOT
TABLE 151. CORIS BIOCONCEPT: PRODUCT SEGMENTS
TABLE 152. CORIS BIOCONCEPT: PRODUCT PORTFOLIO
TABLE 153. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 154. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 155. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 156. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. ENTERIC DISEASE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ENTERIC DISEASE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN ENTERIC DISEASE TESTING MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALENTERIC DISEASE TESTING MARKET
FIGURE 10. ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR EQUIPMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR BACTERIAL ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR VIRAL ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR PARASITIC ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. ENTERIC DISEASE TESTING MARKET, BY END USER, 2022(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. ENTERIC DISEASE TESTING MARKET BY REGION, 2022
FIGURE 25. U.S. ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 26. CANADA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 27. MEXICO ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 28. GERMANY ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 29. FRANCE ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 30. UK ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 31. ITALY ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 32. SPAIN ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 33. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 34. JAPAN ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 35. CHINA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 36. AUSTRALIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 37. INDIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 38. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 40. BRAZIL ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 41. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 42. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 43. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 48. COMPETITIVE DASHBOARD
FIGURE 49. COMPETITIVE HEATMAP: ENTERIC DISEASE TESTING MARKET
FIGURE 50. TOP PLAYER POSITIONING, 2022
FIGURE 51. BECTON DICKINSON & COMPANY: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 52. BECTON DICKINSON & COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 53. BECTON DICKINSON & COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 54. BECTON DICKINSON & COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 55. BIOMERICA, INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 56. BIOMERICA, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
FIGURE 57. BIOMERICA, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 58. BIOMERIEUX SA: NET SALES, 2019-2021 ($MILLION)
FIGURE 59. BIOMERIEUX SA: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 60. BIOMERIEUX SA: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 61. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
FIGURE 62. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. DIASORIN S.P.A.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 65. DIASORIN S.P.A.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 66. MERIDIAN BIOSCIENCE INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 67. MERIDIAN BIOSCIENCE INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
FIGURE 68. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 69. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. QUEST DIAGNOSTICS INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 71. QUEST DIAGNOSTICS INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 72. TRINITY BIOTECH: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 73. TRINITY BIOTECH: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 74. TRINITY BIOTECH: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 75. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 76. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 77. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
